Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
8.68
-0.08 (-0.91%)
Jan 21, 2026, 4:08 PM HKT
HKG:3613 Revenue
Beijing Tong Ren Tang Chinese Medicine Company had revenue of 761.74M HKD in the half year ending June 30, 2025, a decrease of -6.28%. This brings the company's revenue in the last twelve months to 1.71B, up 24.13% year-over-year. In the year 2024, Beijing Tong Ren Tang Chinese Medicine Company had annual revenue of 1.61B with 5.69% growth.
Revenue (ttm)
1.71B
Revenue Growth
+24.13%
P/S Ratio
4.29
Revenue / Employee
2.17M
Employees
782
Market Cap
7.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.61B | 86.70M | 5.69% |
| Dec 31, 2023 | 1.52B | -206.15M | -11.91% |
| Dec 31, 2022 | 1.73B | 174.94M | 11.24% |
| Dec 31, 2021 | 1.56B | 240.81M | 18.31% |
| Dec 31, 2020 | 1.32B | -117.29M | -8.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| CSPC Pharmaceutical Group | 28.65B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |